PMID- 10674384 OWN - NLM STAT- MEDLINE DCOM- 20000314 LR - 20191103 IS - 1087-0024 (Print) IS - 1087-0024 (Linking) VI - 4 IP - 3 DP - 1999 Dec TI - In vitro main pathways of steroid action in cultured hair follicle cells: vascular approach. PG - 290-5 AB - The known role of steroids on the hair follicle leads us to investigate their effects on hair follicle cell angiogenic responses in vitro. We verified, using the immunohistochemical technique, whether human occipital scalp follicle cells express steroid receptors in vitro. We showed that androgen and estrogen receptors were expressed by dermal papilla cells (DPC) and keratinocytes from the outer root sheath in vitro. With regard to steroidal enzymes (type I and II 5alpha-reductases and Cytochrome-p-450-aromatase), the type I 5alpha-reductase gene is much more expressed in DPC than in dermal fibroblasts; however, the type II 5a-reductase gene is transcribed more in dermal fibroblasts than in DPC. The transcription of the two 5alpha-reductase isoform genes in cultured DPC is regulated by a 5alpha-reductase inhibitor. We also demonstrated that DPC, dermal fibroblasts, and outer root shealth keratinocytes expressed cytochrome-p-450-aromatase. Using ELISA and reverse transcriptase-polymerase chain reaction, we investigated the role played by some steroids (estrogens, androgens, antiandrogens) in the modulation of vascular endothelial growth factor (VEGF) expression by DPC. The association of different treatments of DPC (5alpha-reductase inhibitor and androgen receptor antagonist) shows a great stimulation of VEGF and aromatase expression. Strong stimulation of VEGF protein and gene expression is observed in the presence of 17beta-estradiol. Also, the concentration-dependent inhibition of VEGF expression by DPC using the cytochrome-p-450-aromatase inhibitor, confirms the involvement of this estrogenic pathway in the regulation of VEGF expression in vitro. FAU - Lachgar, S AU - Lachgar S AD - Laboratoire de Biologie Cellulaire Cutanee, Institut de Recherche Pierre Fabre, Faculte de Medecine Rangueil, Toulouse, France. souad.lachgar@pierre-fabre.com FAU - Charveron, M AU - Charveron M FAU - Sarraute, J AU - Sarraute J FAU - Mourard, M AU - Mourard M FAU - Gall, Y AU - Gall Y FAU - Bonafe, J L AU - Bonafe JL LA - eng PT - Journal Article PL - United States TA - J Investig Dermatol Symp Proc JT - The journal of investigative dermatology. Symposium proceedings JID - 9609059 RN - 0 (Androgens) RN - 0 (Endothelial Growth Factors) RN - 0 (Estrogens) RN - 0 (Lymphokines) RN - 0 (Receptors, Androgen) RN - 0 (Receptors, Estrogen) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (Vascular Endothelial Growth Factors) SB - IM MH - Androgens/pharmacology MH - Animals MH - Cells, Cultured MH - Endothelial Growth Factors/*physiology MH - Estrogens/pharmacology MH - Gene Expression Regulation/physiology MH - Hair Follicle/blood supply/drug effects/*physiology MH - Humans MH - Lymphokines/*physiology MH - Mice MH - Neovascularization, Physiologic/*drug effects MH - Receptors, Androgen/*physiology MH - Receptors, Estrogen/*physiology MH - Signal Transduction/*drug effects MH - Vascular Endothelial Growth Factor A MH - Vascular Endothelial Growth Factors EDAT- 2000/02/16 09:00 MHDA- 2000/03/18 09:00 CRDT- 2000/02/16 09:00 PHST- 2000/02/16 09:00 [pubmed] PHST- 2000/03/18 09:00 [medline] PHST- 2000/02/16 09:00 [entrez] AID - S1087-0024(15)30285-9 [pii] AID - 10.1038/sj.jidsp.5640232 [doi] PST - ppublish SO - J Investig Dermatol Symp Proc. 1999 Dec;4(3):290-5. doi: 10.1038/sj.jidsp.5640232.